ESOLONG® ESOLONG®
ESOLONG®
  • Type of the medical product: antisecretory parenteral drug
  • Pharmaceutical form: powder for solution for injection or infusion
  • Composition: 1 vial contains esomeprazole sodium 42,60 mg, equivalent to esomeprazole 40 mg; disodium edetate (Trilon B), sodium hydroxide
  • Indication:

    Adults:

    ∙ Antisecretory therapy when it is impossible to use the oral route of administration:

    - gastroesophageal reflux disease in patients with esophagitis and / or severe reflux symptoms;

    - treatment of gastric ulcers associated with the treatment of nonsteroidal anti-inflammatory drugs (NSAIDs);

    - prevention of gastric and duodenal ulcers associated with NSAID therapy in at-risk patients.

    ∙ Short-term maintenance of hemostasis and prevention of recurrent bleeding in patients after endoscopic treatment of acute bleeding due to the ulcer of stomach or duodenum.

    Children from 1 to 18 years:

    ∙ Antisecretory therapy when it is impossible to use the oral route of administration:

    - gastroesophageal reflux disease (GERD) in patients with erosive reflux esophagitis and / or severe reflux symptoms.